HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Merck & Co., Inc. (MRK)
81.285  -1.255  (-1.52%) 08-04 15:34
Open: 82.15 High: 82.55
Pre.close: 82.54 Low: 81.08
Volume: 4,910,153 Ave vol: 9,804,817
52w High: 92.64 52w Low: 65.25
MA(50): 77.977 MA(200): 79.533
EPS: 4.104 P/E Ratio: 19.81
Company profile
Exchange: NYSE
Sector: Healthcare
Industry: Drug ManufacturersGeneral
Website: http://www.merck.com
Market Cap (M): 205,171
Shares Out (M): 2,524
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases.
Technical analysis
Overall: Outperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 97.88 Target 2: 114.32
Resist 1: 83.80 Resist 2: 97.88
Support 1: 79.00 Support 2: 76.04
Company key metrics
Revenue per Share: 18.2612
Net Income per Share: 3.8374
Cash per Share: 3.7723
Book Value per Share: 10.1002
Price to Sales: 4.7368
Price to Book Value: 8.5642
Earnings Yield: 0.0444
Dividend Yield: 0.0257
Debt to Equity: 2.2577
Debt to Assets: 0.693
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Outperform
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts
Headline news
Tue, 04 Aug 2020
Merck betting on 'swish-and-swallow' COVID vaccine - Bioprocess Insider - BioProcess Insider

Tue, 04 Aug 2020
Merck bags J&J castoff from Hanmi to expand NASH pipeline - FierceBiotech

Tue, 04 Aug 2020
Global Veterinary Vaccine Market Development 2020 | Merck, Ringpu Biology, Boehringer Ingelheim, Zoetis - Counter Current

Mon, 03 Aug 2020
Merck's First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3 - HospiMedica

Mon, 03 Aug 2020
Dow's 200-point climb led by gains in shares of Microsoft, Merck - MarketWatch

Mon, 03 Aug 2020
Buy Merck Stock for Its Unappreciated Pipeline, Says Goldman - Barron's

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.